What is your first choice TKI for pediatric patients with Ph+ ALL who are not on a study?
Community PollStarted
What is your preferred TKI for Ph+ ALL?
2 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet MemberInvited Expert
Pediatric Hematology/Oncology · New York University School of Medicine
Answered on
The first choice for TKI in children/adolescents with Ph+ ALL should be dasatinib based on a recent study published in JAMA Oncology (Shen et al).
Join for free or sign in to see the full answer